Neutralizing proprotein convertase subtilisin kexin type 9 ( PCSK9) variants and uses thereof

Details for Australian Patent Application No. 2009238550 (hide)

Owner Amgen Inc.

Inventors Piper, Derek Evan; Jackson, Simon Mark

Agent Shelston IP

Pub. Number AU-A-2009238550

PCT Pub. Number WO2009/131740

Priority 61/125,304 23.04.08 US

Filing date 20 February 2009

Wipo publication date 29 October 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/131740 Priority application(s): WO2009/131740

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238553-Model for early adoption and retention of sources of funding to finance award program

2009238548-Microcurrent-generating topical or cosmetic systems, and methods of making and using the same